Search research articles
Contact Us
Filters
Showing results (221-230 of 472) with videos related to
Page
of 48
Sort By:
Journal of the National Cancer Institute
|
September 1, 1978
Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon
J L Crane, L A Glasgow, E R Kern, et al.
The Journal of Clinical Investigation
|
June 1, 1993
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models
R J Whitley, E R Kern, S Chatterjee, et al.
Biomedizinische Technik. Biomedical Engineering
|
January 1, 1997
[Measuring cerebral blood flow using electron beam computerized tomography]
C Baumgartner, R Rienmüller, B Melisch, et al.
Antiviral Chemistry & Chemotherapy
|
October 18, 2006
Short communication inhibitory activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethylpyrimidin-2-yl) benzenesulphonamide and its derivatives against orthopoxvirus replication in vitro
Periyasamy Selvam, Narayanan Murugesh, Markandavel Chandramohan, et al.
Intervirology
|
January 1, 1985
Recurrent genital herpes simplex virus infection in guinea pigs
L R Stanberry, E R Kern, J T Richards, et al.
Biomedizinische Technik. Biomedical Engineering
|
December 22, 1998
[Determining cerebral circulation with electron beam computerized tomography]
C Baumgartner, R Rienmüller, B Melisch, et al.
The Journal of Infectious Diseases
|
April 1, 1977
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus
D A Stringfellow, E R Kern, D K Kelsey, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1976
Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice
G A Olsen, E R Kern, L A Glasgow, et al.
Journal of Neurology
|
February 22, 2012
Multiple subcortical acute ischemic lesions reflect small vessel disease rather than cardiogenic embolism
M E Wolf, T Sauer, R Kern, et al.
Antiviral Chemistry & Chemotherapy
|
October 12, 2001
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections
E R Kern, R J Rybak, C B Hartline, et al.
Page
of 48
Search research articles
Search
Showing results (221-230 of 472) with videos related to
Sort By:
Page
of 48
Journal of the National Cancer Institute
|
September 1, 1978
Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon
J L Crane, L A Glasgow, E R Kern, et al.
The Journal of Clinical Investigation
|
June 1, 1993
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models
R J Whitley, E R Kern, S Chatterjee, et al.
Biomedizinische Technik. Biomedical Engineering
|
January 1, 1997
[Measuring cerebral blood flow using electron beam computerized tomography]
C Baumgartner, R Rienmüller, B Melisch, et al.
Antiviral Chemistry & Chemotherapy
|
October 18, 2006
Short communication inhibitory activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethylpyrimidin-2-yl) benzenesulphonamide and its derivatives against orthopoxvirus replication in vitro
Periyasamy Selvam, Narayanan Murugesh, Markandavel Chandramohan, et al.
Intervirology
|
January 1, 1985
Recurrent genital herpes simplex virus infection in guinea pigs
L R Stanberry, E R Kern, J T Richards, et al.
Biomedizinische Technik. Biomedical Engineering
|
December 22, 1998
[Determining cerebral circulation with electron beam computerized tomography]
C Baumgartner, R Rienmüller, B Melisch, et al.
The Journal of Infectious Diseases
|
April 1, 1977
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus
D A Stringfellow, E R Kern, D K Kelsey, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1976
Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice
G A Olsen, E R Kern, L A Glasgow, et al.
Journal of Neurology
|
February 22, 2012
Multiple subcortical acute ischemic lesions reflect small vessel disease rather than cardiogenic embolism
M E Wolf, T Sauer, R Kern, et al.
Antiviral Chemistry & Chemotherapy
|
October 12, 2001
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections
E R Kern, R J Rybak, C B Hartline, et al.
Page
of 48